The phenomenon that EphB2 has both anti-proliferative and pro-migratory effects in vivo may reflect the migration/proliferation dichotomy of GBM, whereas its underlying molecular mechanisms are largely unclear (Giese et al., 1996; Giese et al., 2003). Here, EPHB2 is linked to glioblastoma.